Preclinical characterization of the efficacy and safety of histamine H(3) receptor antagonist, LINS01022, as a novel analgesic for chronic neuropathic pain treatment.
- DOI
- 10.1016/j.ejphar.2026.179265
- Published
- 2026 Oct 28
- Container
- European journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179265,
title = {Preclinical characterization of the efficacy and safety of histamine H(3) receptor antagonist, LINS01022, as a novel analgesic for chronic neuropathic pain treatment.},
author = {Maciuszek M and Białoń M and Królewski M and Noworyta K and Fiocchi NA and Lopes FB and Starowicz K and Gouveia WL and Lima LM and Fernandes JPS and Popiolek-Barczyk K},
year = {2026},
journal = {European journal of pharmacology},
doi = {10.1016/j.ejphar.2026.179265},
url = {https://doi.org/10.1016/j.ejphar.2026.179265}
}RIS
TY - JOUR TI - Preclinical characterization of the efficacy and safety of histamine H(3) receptor antagonist, LINS01022, as a novel analgesic for chronic neuropathic pain treatment. AU - Maciuszek M AU - Białoń M AU - Królewski M AU - Noworyta K AU - Fiocchi NA AU - Lopes FB AU - Starowicz K AU - Gouveia WL AU - Lima LM AU - Fernandes JPS AU - Popiolek-Barczyk K PY - 2026 JO - European journal of pharmacology DO - 10.1016/j.ejphar.2026.179265 UR - https://doi.org/10.1016/j.ejphar.2026.179265 ER -
APA
M, M., M, B., M, K., K, N., NA, F., FB, L., K, S., WL, G., LM, L., JPS, F., & K, P. (2026). Preclinical characterization of the efficacy and safety of histamine H(3) receptor antagonist, LINS01022, as a novel analgesic for chronic neuropathic pain treatment.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179265
Source records
- pubmed · retrieved 2026-09-25T20:55:37.416Z